Endpoints News 27 janv. 2026 CMS picks Lilly’s Trulicity, Gilead's Biktarvy for third round of Medicare negotiations
Endpoints News 23 janv. 2026 Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO
Endpoints News 22 déc. 2025 Aktis Oncology files for IPO to fund Lilly-partnered radiopharma pipeline
Endpoints News 18 déc. 2025 Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting
Endpoints News 11 déc. 2025 Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reported